Abstract
We receive, from time to time, tantalizing bits of information and misinformation concerning fibrous conversion of the marrow. Forty years ago, we believed that removal of the large spleens of myelofibrosis was a too-great risk. 1 At that time, we subscribed to Donhauser's dictum that the metaplastic spleen in myelofibrosis with myeloid metaplasia (MFM) was the only source of blood cells, having resumed its fetal hemopoietic function. 2 Now we know it isn't true. The hemopoietic tissue in MFM is neoplastic with neoplastic cell-lines in the marrow and in the spleen; the two organs become involved simultaneously. The spleen's metaplasia is not a reaction to the marrow's abdication; the marrow is often hypercellular before it becomes fibrotic. 3 The fibrous tissue is not a part of the abnormal neoplastic clone: marrow fibroblasts do not share the chromosomal abnormalities that are often present in the neoplastic hemopoietic cells of the myeloproliferative
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
